Accès gratuit
Numéro
Med Sci (Paris)
Volume 30, Numéro 1, Janvier 2014
Page(s) 9 - 12
Section Nouvelles
DOI https://doi.org/10.1051/medsci/20143001002
Publié en ligne 24 janvier 2014
  1. Rekand T, Gronning M. Treatment of spasticity related to multiple sclerosis with intrathecal baclofen: a long-term follow-up. J Rehabil Med 2011 ; 43 : 511–514. [CrossRef] [PubMed]
  2. Gorsane MA, Kebir O, Hache G, et al. Is baclofen a revolutionary medication in alcohol addiction management? Review and recent updates. Subst Abus 2012 ; 33: 336–349. [CrossRef]
  3. Addolorato G, Leggio L, Agabio R, et al. Baclofen: a new drug for the treatment of alcohol dependence. Int J Clin Pract 2006 ; 60 : 1003–1008. [CrossRef] [PubMed]
  4. Bowery NG. GABAB receptor pharmacology. Annu Rev Pharmacol Toxicol 1993 ; 33 : 109–147. [CrossRef] [PubMed]
  5. Froestl, W. Chemistry and pharmacology of GABAB receptor ligands. Adv Pharmacol 2010 ; 58 : 19–62. [CrossRef] [PubMed]
  6. Guyon A, Kussrow A, Olmsted IR, et al. Baclofen and other GABAB receptor agents are allosteric modulators of the CXCL12 chemokine receptor CXCR4. J Neurosci 2013 ; 33 : 11643–11654. [CrossRef] [PubMed]
  7. Banisadr G, Rostene W, Kitabgi P, Parsadaniantz S. Chemokines and brain functions. Curr Drug Targets Inflamm Allergy 2005 ; 4 : 387–399. [CrossRef] [PubMed]
  8. Guyon A, Massa F, Rovere C, Nahon JL. How cytokines can influence the brain: a role for chemokines? J Neuroimmunol 2008 ; 198 : 46–55. [CrossRef] [PubMed]
  9. Toth PT, Ren D, Miller RJ. Regulation of CXCR4 receptor dimerization by the chemokine SDF-1alpha and the HIV-1 coat protein gp120: a fluorescence resonance energy transfer (FRET) study. J Pharmacol Exp Ther 2004 ; 310 : 8–17. [CrossRef] [PubMed]
  10. Ortega A. A new role for GABA: inhibition of tumor cell migration. Trends Pharmacol Sci 2003 ; 24 : 151–154. [CrossRef] [PubMed]
  11. Guyon A, Skrzydelski D, Rovère C, et al. Stromal-cell-derived factor 1alpha /CXCL12 modulates high-threshold calcium currents in rat substantia nigra. Eur J Neurosci 2008 ; 28 : 862–870. [CrossRef] [PubMed]
  12. Pello OM, Martínez-Muñoz L, Parrillas V, et al. Ligand stabilization of CXCR4/delta-opioid receptor heterodimers reveals a mechanism for immune response regulation. Eur J Immunol 2008 ; 38 : 537–549. [CrossRef] [PubMed]
  13. Sohy D, Parmentier M, Springael JY. Allosteric transinhibition by specific antagonists in CCR2/CXCR4 heterodimers. J Biol Chem 2007 ; 282 : 30062–30069. [CrossRef] [PubMed]
  14. Percherancier Y, Berchiche YA, Slight I, et al. Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homo- and heterodimers. J Biol Chem 2005 ; 280 : 9895–9903. [CrossRef] [PubMed]
  15. Babcock GJ, Farzan M, Sodroski J. Ligand-independent dimerization of CXCR4, a principal HIV-1 coreceptor. J Biol Chem 2003 ; 278 : 3378–3385. [CrossRef] [PubMed]
  16. Baksh MM, Kussrow AK, Mileni M, et al. Label-free quantification of membrane-ligand interactions using backscattering interferometry. Nat Biotechnol 2011 ; 29 : 357–360. [CrossRef] [PubMed]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.